-
Population-Level Trends in Lifestyle Factors and Early-Onset Breast, Colorectal, and Uterine Cancers. Cancers (Basel). 2026 Jan 03; 18(1). Ayoub NL, Francoeur AA, Chang J, Tran N, Tewari KS, Kapp DS, Bristow RE, Chan JK. PMID: 41514674; PMCID: PMC12784836.
-
Survival impact and prognostic factors of secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a systematic review and trial-level meta-analysis. Int J Gynecol Cancer. 2026 Jan; 36(1):102756. Kim JH, Lim MC, Kim ET, Kim U, Halder S, Park SY, Harter P, Bristow R, Zang R, Chi D, Fotopoulou C. PMID: 41259845.
-
Racial/ethnic disparities in time from diagnosis to surgical treatment for type I and type II endometrial carcinomas. Gynecol Oncol. 2025 Aug; 199:139-146. Rodriguez VE, Ro A, Hoyt MA, Tanjasiri SP, Bristow RE, LeBrón AMW. PMID: 40639063.
-
Isolated low-grade serous carcinoma arising in inguinal lymph nodes in the setting of endosalpingiosis: A case report. Gynecol Oncol Rep. 2025 Jun; 59:101769. Solaru SA, Liu MC, Lee V, Bristow RE. PMID: 40502817; PMCID: PMC12158510.
-
Growing teratoma syndrome with extra pelvic metastasis and gliomatosis peritonei. Gynecol Oncol Rep. 2025 Apr; 58:101731. File B, Lee S, Bristow R. PMID: 40226597; PMCID: PMC11993180.
-
Trends in endometrial cancer incidence in the United States by race/ethnicity and age of onset from 2000 to 2019. Am J Epidemiol. 2025 Jan 08; 194(1):103-113. Rodriguez VE, Tanjasiri SP, Ro A, Hoyt MA, Bristow RE, LeBrón AMW. PMID: 38960701; PMCID: PMC12034838.
-
Trends in the incidence and mutational landscape of advanced uterine cancer. Int J Gynecol Cancer. 2025 Jan; 35(1):100013. Francoeur AA, Liao CI, Johnson CR, Argueta C, Tian C, Darcy KM, Kapp DS, Bristow RE, Chan JK. PMID: 39878271.
-
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy. Int J Radiat Oncol Biol Phys. 2025 Mar 01; 121(3):752-760. Reardon MD, Bibby BAS, Thiruthaneeswaran N, Pereira RR, Mistry H, More E, Tsang Y, Vickers AJ, Reeves KJ, Henry A, Denley H, Wylie J, Spratt DE, Hakansson A, Ryu M, Smith TAD, Hoskin PJ, Bristow R, Choudhury A, West CML. PMID: 39424079.
-
Emergency cesarean section in pregnant trauma patients presenting after motor vehicle collision. Heliyon. 2024 Oct 15; 10(19):e38707. Hough M, Nahmias J, Santos J, Swentek L, Bristow R, Butler J, Grigorian A. PMID: 39435102; PMCID: PMC11491900.
-
Response to: Correspondence on 'Medicolegal, infrastructural,and financial aspects in gynecologic cancer surgery and their implications in decision making processes: Quo Vadis?' by Nevin and Bolton. Int J Gynecol Cancer. 2024 08 05; 34(8):1311. Allanson E, Cohen PA, Bristow R. PMID: 38851241.
-
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer. Cochrane Database Syst Rev. 2024 06 27; 6:CD015297. Pappa C, Galaal K, Smyth S, Bristow RE, Khashan AS, Alazzam M. PMID: 38934360; PMCID: PMC11209860.
-
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer. BMC Cancer. 2024 Jun 18; 24(1):744. Ci X, Chen S, Zhu R, Zarif M, Jain R, Guo W, Ramotar M, Gong L, Xu W, Singh O, Mansouri S, Zadeh G, Wei GH, Xu W, Bristow R, Berlin A, Koritzinsky M, van der Kwast T, He HH. PMID: 38890593; PMCID: PMC11186205.
-
Medicolegal, infrastructural, and financial aspects in gynecologic cancer surgery and their implications in decision making processes: Quo Vadis? Int J Gynecol Cancer. 2024 03 04; 34(3):451-458. Allanson E, Hari A, Ndaboine E, Cohen PA, Bristow R. PMID: 38438180.
-
Short-term survival analysis of a risk-adjusted model for ovarian cancer care. Gynecol Oncol. 2024 05; 184:123-131. Hari A, Chang J, Villanueva C, Ziogas A, Vieira V, Bristow RE. PMID: 38309029; PMCID: PMC12664122.
-
Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis. Gynecol Oncol. 2023 Oct 27; 179:24-32. Kim JH, Kim SI, Park EY, Ha HI, Kim JW, Coleman RL, Bristow RE, Park SY, Fotopoulou C, Lim MC. PMID: 39491079.
-
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis. J Clin Oncol. 2023 09 01; 41(25):4065-4076. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. PMID: 37643543.
-
Fertility sparing treatment of vaginal clear cell adenocarcinoma in a DES-Naïve young woman. Gynecol Oncol Rep. 2023 Aug; 48:101214. Chambers ME, Bristow R, Tseng J. PMID: 37325294; PMCID: PMC10265479.
-
Differential Effects of Race, Socioeconomic Status, and Insurance on Disease-Specific Survival in Rectal Cancer. Dis Colon Rectum. 2023 09 01; 66(9):1263-1272. Del Rosario M, Chang J, Ziogas A, Clair K, Bristow RE, Tanjasiri SP, Zell JA. PMID: 35849491; PMCID: PMC10548716.
-
Population-Based Analysis of National Comprehensive Cancer Network (NCCN) Guideline Adherence for Patients with Anal Squamous Cell Carcinoma in California. Cancers (Basel). 2023 Feb 25; 15(5). Kumar P, Del Rosario M, Chang J, Ziogas A, Jafari MD, Bristow RE, Tanjasiri SP, Zell JA. PMID: 36900256; PMCID: PMC10000877.
-
T-Cell Infiltration and Clonality May Identify Distinct Survival Groups in Colorectal Cancer: Development and Validation of a Prognostic Model Based on The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC). Cancers (Basel). 2022 Nov 29; 14(23). Campana LG, Mansoor W, Hill J, Macutkiewicz C, Curran F, Donnelly D, Hornung B, Charleston P, Bristow R, Lord GM, Valpione S. PMID: 36497365; PMCID: PMC9740634.
-
Spatial-Temporal Trends in Ovarian Cancer Outcomes in California. JNCI Cancer Spectr. 2022 11 01; 6(6). Villanueva C, Chang J, Ziogas A, Bristow RE, Vieira VM. PMID: 36238987; PMCID: PMC9667974.
-
Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis. Gynecol Oncol. 2022 Dec; 167(3):547-556. Kim SI, Kim JH, Lee S, Cho H, van Driel WJ, Sonke GS, Bristow RE, Park SY, Fotopoulou C, Lim MC. PMID: 36273925.
-
Complications associated with cytoreductive surgery for advanced ovarian cancer: Surgical timing and surmounting obstacles. Gynecol Oncol. 2022 07; 166(1):5-7. Tseng JH, Bristow RE. PMID: 35725134.
-
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer. Mol Cancer. 2022 03 22; 21(1):82. Fletcher CE, Deng L, Orafidiya F, Yuan W, Lorentzen MPGS, Cyran OW, Varela-Carver A, Constantin TA, Leach DA, Dobbs FM, Figueiredo I, Gurel B, Parkes E, Bogdan D, Pereira RR, Zhao SG, Neeb A, Issa F, Hester J, Kudo H, Liu Y, Philippou Y, Bristow R, Knudsen K, Bryant RJ, Feng FY, Reed SH, Mills IG, de Bono J, Bevan CL. PMID: 35317841; PMCID: PMC8939142.
-
Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis. J Clin Oncol. 2022 05 20; 40(15):1659-1670. Baek MH, Park EY, Ha HI, Park SY, Lim MC, Fotopoulou C, Bristow RE. PMID: 35188810.
-
The urban-rural gap: Disparities in ovarian cancer survival among patients treated in tertiary centers. Gynecol Oncol. 2021 10; 163(1):3-4. Clair KH, Bristow RE. PMID: 34629166.
-
Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis. Gynecol Oncol. 2021 10; 163(1):162-170. D'Amora P, Silva IDCG, Tewari KS, Bristow RE, Cappuccini F, Evans SS, Salzgeber MB, Addis-Bernard PJ, Palma AM, Marchioni DML, Carioca AAF, Penner KR, Alldredge J, Longoria T, Nagourney RA. PMID: 34446269.
-
Looking at cancer health disparities in gynecologic oncology in 2020. Curr Opin Obstet Gynecol. 2021 08 01; 33(4):355-359. Clair K, Bristow RE. PMID: 34183551.
-
Ambient air pollution and ovarian cancer survival in California. Gynecol Oncol. 2021 10; 163(1):155-161. Villanueva C, Chang J, Ziogas A, Bristow RE, Vieira VM. PMID: 34330535; PMCID: PMC8511076.
-
Racial-Ethnic and Socioeconomic Disparities in Guideline-Adherent Treatment for Endometrial Cancer. Obstet Gynecol. 2021 07 01; 138(1):21-31. Rodriguez VE, LeBrón AMW, Chang J, Bristow RE. PMID: 34259460; PMCID: PMC10403994.
-
Rectosigmoid resection by gynecologic oncologists versus colorectal surgeons: as long as it catches the mouse, does the color of the cat matter? J Gynecol Oncol. 2021 05; 32(3):e51. Chang SJ, Fotopoulou C, Bristow RE, Chi DS, Cliby WA. PMID: 33825361; PMCID: PMC8039173.
-
Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas. Cancer. 2021 07 15; 127(14):2423-2431. Rodriguez VE, LeBrón AMW, Chang J, Bristow RE. PMID: 33721357; PMCID: PMC8249350.
-
Unanticipated 30-day readmission following rectosigmoid resection at the time of cytoreductive surgery in patients with advanced stage ovarian cancer. J Obstet Gynaecol. 2021 Aug; 41(6):956-961. Sanders BE, Saharti S, Laus K, Bristow RE, Eskander RN. PMID: 33228421.
-
Ovarian cancer in California: Guideline adherence, survival, and the impact of geographic location, 1996-2014. Cancer Epidemiol. 2020 12; 69:101825. Villanueva C, Chang J, Ziogas A, Bristow RE, Vieira VM. PMID: 33022472; PMCID: PMC7710533.
-
Incidence Rates of Gynecologic Cancers in the U.S. Active Duty Military Population. Mil Med. 2020 09 18; 185(9-10):e1590-e1595. Owens S, Blando T, Tesema YB, Butts E, Newton J, Bristow R, Randall LM. PMID: 32495838.
-
Successful treatment of metastatic refractory gestational choriocarcinoma with pembrolizumab: A case for immune checkpoint salvage therapy in trophoblastic tumors. Gynecol Oncol Rep. 2020 Nov; 34:100625. Clair KH, Gallegos N, Bristow RE. PMID: 32964090; PMCID: PMC7490982.
-
Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management. Eur J Surg Oncol. 2020 12; 46(12):2292-2310. Hübner M, Kusamura S, Villeneuve L, Al-Niaimi A, Alyami M, Balonov K, Bell J, Bristow R, Guiral DC, Fagotti A, Falcão LFR, Glehen O, Lambert L, Mack L, Muenster T, Piso P, Pocard M, Rau B, Sgarbura O, Somashekhar SP, Wadhwa A, Altman A, Fawcett W, Veerapong J, Nelson G. PMID: 32873454.
-
Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part II: Postoperative management and special considerations. Eur J Surg Oncol. 2020 12; 46(12):2311-2323. Hübner M, Kusamura S, Villeneuve L, Al-Niaimi A, Alyami M, Balonov K, Bell J, Bristow R, Guiral DC, Fagotti A, Falcão LFR, Glehen O, Lambert L, Mack L, Muenster T, Piso P, Pocard M, Rau B, Sgarbura O, Somashekhar SP, Wadhwa A, Altman A, Fawcett W, Veerapong J, Nelson G. PMID: 32826114.
-
Specific requirements for translation of biological research into clinical radiation oncology. Mol Oncol. 2020 07; 14(7):1569-1576. Krause M, Alsner J, Linge A, Bütof R, Löck S, Bristow R. PMID: 32175659; PMCID: PMC7332213.
-
A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals. Obstet Gynecol. 2020 02; 135(2):328-339. Bristow RE, Chang J, Villanueva C, Ziogas A, Vieira VM. PMID: 31923082; PMCID: PMC7012338.
-
Contribution of Geographic Location to Disparities in Ovarian Cancer Treatment. J Natl Compr Canc Netw. 2019 11 01; 17(11):1318-1329. Villanueva C, Chang J, Bartell SM, Ziogas A, Bristow R, Vieira VM. PMID: 31693984; PMCID: PMC6839545.
-
Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for laryngeal cancer. Laryngoscope. 2020 03; 130(3):672-678. Swegal WC, Herbert RJ, Eisele DW, Chang J, Bristow RE, Gourin CG. PMID: 31169916.
-
Impact of hospital care volume on clinical outcomes of laparoscopic radical hysterectomy for cervical cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2018 Dec; 97(49):e13445. Lee B, Kim K, Park Y, Lim MC, Bristow RE. PMID: 30544427; PMCID: PMC6310549.
-
It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer. Gynecol Oncol. 2018 12; 151(3):555-561. Zivanovic O, Chi DS, Filippova O, Randall LM, Bristow RE, O'Cearbhaill RE. PMID: 30249527; PMCID: PMC6684262.
-
Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study. BMC Cancer. 2018 Aug 08; 18(1):800. Lim MC, Won YJ, Lim J, Salehi T, Yoo CW, Bristow RE. PMID: 30089478; PMCID: PMC6083613.
-
Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California. Obstet Gynecol. 2018 05; 131(5):899-908. Pfaendler KS, Chang J, Ziogas A, Bristow RE, Penner KR. PMID: 29630020; PMCID: PMC5912990.
-
Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma. PLoS One. 2018; 13(5):e0194809. Teichman J, Dodbiba L, Thai H, Fleet A, Morey T, Liu L, McGregor M, Cheng D, Chen Z, Darling G, Brhane Y, Song Y, Espin-Garcia O, Xu W, Girgis H, Schwock J, MacKay H, Bristow R, Ailles L, Liu G. PMID: 29715275; PMCID: PMC5929523.
-
Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017. Clin Cancer Res. 2018 08 01; 24(15):3500-3509. Okunieff P, Casey-Sawicki K, Lockney NA, Hoppe BS, Enderling H, Pinnix C, Welsh J, Krishnan S, Yothers G, Brown M, Knox S, Bristow R, Spellman P, Mitin T, Nabavizadeh N, Jaboin J, Manning HC, Feng F, Galbraith S, Solanki AA, Harkenrider MM, Tuli R, Decker RH, Finkelstein SE, Hsu CC, Ha CS, Jagsi R, Shumway D, Daly M, Wang TJC, Fitzgerald TJ, Laurie F, Marshall DT, Raben D, Constine L, Thomas CR, Kachnic LA. PMID: 29661779.
-
The Future of Radiobiology. J Natl Cancer Inst. 2018 04 01; 110(4):329-340. Kirsch DG, Diehn M, Kesarwala AH, Maity A, Morgan MA, Schwarz JK, Bristow R, Demaria S, Eke I, Griffin RJ, Haas-Kogan D, Higgins GS, Kimmelman AC, Kimple RJ, Lombaert IM, Ma L, Marples B, Pajonk F, Park CC, Schaue D, Tran PT, Bernhard EJ. PMID: 29126306; PMCID: PMC5928778.
-
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2018 06; 149(3):525-530. Eskander RN, Kauderer J, Tewari KS, Mannel RS, Bristow RE, O'Malley DM, Rubin SC, Glaser GE, Hamilton CA, Fujiwara K, Huh WK, Ueland F, Stephan JM, Burger RA. PMID: 29550184; PMCID: PMC7265815.
-
Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae. J Cancer Res Clin Oncol. 2018 May; 144(5):845-854. Lim MC, Won YJ, Lim J, Seo SS, Kang S, Yoo CW, Kim JY, Oh JH, Bristow RE, Park SY. PMID: 29445866; PMCID: PMC5916981.
-
Geographic disparities in the distribution of the U.S. gynecologic oncology workforce: A Society of Gynecologic Oncology study. Gynecol Oncol Rep. 2017 Nov; 22:100-104. Ricci S, Tergas AI, Long Roche K, Fairbairn MG, Levinson KL, Dowdy SC, Bristow RE, Lopez M, Slaughter K, Moore K, Fader AN. PMID: 29201989; PMCID: PMC5699889.
-
A Review of Thoracic and Mediastinal Cytoreductive Techniques in Advanced Ovarian Cancer: Extending the Boundaries. Ann Surg Oncol. 2017 Nov; 24(12):3700-3705. Nasser S, Kyrgiou M, Krell J, Haidopoulos D, Bristow R, Fotopoulou C. PMID: 28861808.
-
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol. 2018 02; 73(2):178-211. Gillessen S, Attard G, Beer TM, Beltran H, Bossi A, Bristow R, Carver B, Castellano D, Chung BH, Clarke N, Daugaard G, Davis ID, de Bono J, Borges Dos Reis R, Drake CG, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Higano CS, James N, Kantoff P, Kellokumpu-Lehtinen PL, Khauli RB, Kramer G, Logothetis C, Maluf F, Morgans AK, Morris MJ, Mottet N, Murthy V, Oh W, Ost P, Padhani AR, Parker C, Pritchard CC, Roach M, Rubin MA, Ryan C, Saad F, Sartor O, Scher H, Sella A, Shore N, Smith M, Soule H, Sternberg CN, Suzuki H, Sweeney C, Sydes MR, Tannock I, Tombal B, Valdagni R, Wiegel T, Omlin A. PMID: 28655541.
-
Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer-A National Cancer Database Study. Int J Gynecol Cancer. 2017 05; 27(4):675-683. Leiserowitz GS, Lin JF, Tergas AI, Cliby WA, Bristow RE. PMID: 28328580; PMCID: PMC5405779.
-
Impact of community disadvantage and air pollution burden on geographic disparities of ovarian cancer survival in California. Environ Res. 2017 07; 156:388-393. Vieira VM, Villanueva C, Chang J, Ziogas A, Bristow RE. PMID: 28395243; PMCID: PMC5467739.
-
Rationale and study protocol for the Patient-Centered Outcome Aid (PCOA) randomized controlled trial: A personalized decision tool for newly diagnosed ovarian cancer patients. Contemp Clin Trials. 2017 06; 57:29-36. Wenzel L, Mukamel D, Osann K, Havrilesky L, Sparks L, Lipscomb J, Wright AA, Walker J, Alvarez R, Van Le L, Robison K, Bristow R, Morgan R, Rimel BJ, Ladd H, Hsieh S, Wahi A, Cohn D. PMID: 28330753; PMCID: PMC6198815.
-
Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary Cancers. Oncologist. 2017 02; 22(2):152-157. Weinberg BA, Gowen K, Lee TK, Ou SI, Bristow R, Krill L, Almira-Suarez MI, Ali SM, Miller VA, Liu SV, Klempner SJ. PMID: 28193735; PMCID: PMC5330711.
-
Cardiophrenic lymph node metastasis in low-grade serous ovarian adenocarcinoma. Gynecol Oncol Rep. 2017 Feb; 19:31-33. Serna-Gallegos T, Gallegos N, Bristow RE. PMID: 28050597; PMCID: PMC5192095.
-
Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancer. Radiother Oncol. 2017 01; 122(1):93-98. Lieng H, Pintilie M, Bayley A, Berlin A, Bristow R, Chung P, Gospodarowicz M, Huang R, Ménard C, Warde P, Catton C. PMID: 27838147.
-
Perioperative fluid status and surgical outcomes in patients undergoing cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2016 Oct 28. Desale MG, Tanner EJ, Sinno AK, Angarita AA, Fader AN, Stone RL, Levinson KL, Bristow RE, Roche KL. PMID: 28029449.
-
Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis. Gynecol Oncol. 2016 Dec; 143(3):688-689. Kim HS, Bristow RE, Chang SJ. PMID: 27743737.
-
The Utility of Serum CA9 for Prognostication in Prostate Cancer. Anticancer Res. 2016 09; 36(9):4489-92. Smith AD, Truong M, Bristow R, Yip P, Milosevic MF, Joshua AM. PMID: 27630286.
-
Extended left upper quadrant resection during primary cytoreductive surgery for Stage IV ovarian cancer. Gynecol Oncol. 2016 Aug; 142(2):378. Sawyer BT, LaFargue CJ, Bristow RE. PMID: 27264212.
-
Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer. Gynecol Oncol Rep. 2016 Aug; 17:33-7. LaFargue CJ, Sawyer BT, Bristow RE. PMID: 27354998; PMCID: PMC4908458.
-
Surgical management of recurrent ovarian cancer. Gynecol Oncol. 2016 08; 142(2):357-67. Suh DH, Kim HS, Chang SJ, Bristow RE. PMID: 27130407.
-
Refusal of Recommended Chemotherapy for Ovarian Cancer: Risk Factors and Outcomes; a National Cancer Data Base Study. J Natl Compr Canc Netw. 2016 05; 14(5):539-50. Wallace SK, Lin JF, Cliby WA, Leiserowitz GS, Tergas AI, Bristow RE. PMID: 27160232.
-
An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas. J Minim Invasive Gynecol. 2016 Mar-Apr; 23(3):303-8. Parker W, Berek JS, Pritts E, Olive D, Kaunitz AM, Chalas E, Clarke-Pearson D, Goff B, Bristow R, Taylor HS, Farias-Eisner R, Fader AN, Maxwell GL, Goodwin SC, Love S, Gibbons WE, Foshag LJ, Leppert PC, Norsigian J, Nager CW, Johnson T, Guzick DS, As-Sanie S, Paulson RJ, Farquhar C, Bradley L, Scheib SA, Bilchik AJ, Rice LW, Dionne C, Jacoby A, Ascher-Walsh C, Kilpatrick SJ, Adamson GD, Siedhoff M, Israel R, Paraiso MF, Frumovitz MM, Lurain JR, Al-Hendy A, Benrubi GI, Raman SS, Kho RM, Anderson TL, Reynolds RK, DeLancey J. PMID: 26773577.
-
The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysis. Can Urol Assoc J. 2016 Jan-Feb; 10(1-2):25-30. Nayan M, Bhindi B, Yu JL, Mamdani M, Fleshner NE, Hermanns T, Chung P, Milosevic M, Bristow R, Warde P, Hamilton RJ, Finelli A, Jewett MA, Zlotta AR, Sridhar SS, Kulkarni GS. PMID: 26977202; PMCID: PMC4771554.
-
Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost Disparity. Obstet Gynecol. 2016 Jan; 127(1):91-100. Fader AN, Weise RM, Sinno AK, Tanner EJ, Borah BJ, Moriarty JP, Bristow RE, Makary MA, Pronovost PJ, Hutfless S, Dowdy SC. PMID: 26646127.
-
Cost-effectiveness analysis of a multivariate index assay compared to modified American College of Obstetricians and Gynecologists criteria and CA-125 in the triage of women with adnexal masses. Curr Med Res Opin. 2016; 32(2):321-9. Forde GK, Hornberger J, Michalopoulos S, Bristow RE. PMID: 26588255.
-
Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer. Gynecol Oncol. 2015 Dec; 139(3):495-9. Galvan-Turner VB, Chang J, Ziogas A, Bristow RE. PMID: 26387962; PMCID: PMC5145796.
-
There Is Nothing New Under the Sun. J Clin Oncol. 2015 Oct 20; 33(30):3520. Aletti GD, Bristow RE, Chi D, Cliby WA. PMID: 26304883.
-
Finding a needle in a haystack: Ultrasound guided extraction of a sewing needle from the perineum. Case Rep Womens Health. 2015 Jul; 7:3-4. Wang E, Brueseke T, Bristow RE. PMID: 29629307; PMCID: PMC5885997.
-
Role of aggressive surgical cytoreduction in advanced ovarian cancer. J Gynecol Oncol. 2015 Oct; 26(4):336-42. Chang SJ, Bristow RE, Chi DS, Cliby WA. PMID: 26197773; PMCID: PMC4620371.
-
Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practice. Gynecol Oncol. 2015 Sep; 138(3):712-6. Cohn DE, Havrilesky LJ, Osann K, Lipscomb J, Hsieh S, Walker JL, Wright AA, Alvarez RD, Karlan BY, Bristow RE, DiSilvestro PA, Wakabayashi MT, Morgan R, Mukamel DB, Wenzel L. PMID: 26177553; PMCID: PMC4920477.
-
Extensive Tattoos Mimicking Lymphatic Metastasis on Positron Emission Tomography Scan in a Patient With Cervical Cancer. Obstet Gynecol. 2015 Jul; 126(1):182-5. Grove N, Zheng M, Bristow RE, Eskander RN. PMID: 25923020.
-
Reply to A Macrì. J Gynecol Oncol. 2015 Jul; 26(3):242. Chang SJ, Bristow RE. PMID: 26413600.
-
Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention. Gynecol Oncol. 2015 Sep; 138(3):694-9. Dottino JA, Cliby WA, Myers ER, Bristow RE, Havrilesky LJ. PMID: 26072441.
-
Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer. Gynecol Oncol. 2015 Sep; 138(3):762-3. LaFargue CJ, Bristow RE. PMID: 26049122.
-
ROBOTIC SURGERY INCREASES PATIENT's ACCESS TO MINIMALLY INVASIVE SURGERY FOR HYSTERECTOMIES: IGCS-0098 Uterine Cancer, including Sarcoma. Int J Gynecol Cancer. 2015 May; 25 Suppl 1:74. Forde G, Chang J, A Z, Tewari K, Bristow R. PMID: 25955949.
-
Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer. Gynecol Oncol. 2015 Jul; 138(1):121-7. Hodeib M, Chang J, Liu F, Ziogas A, Dilley S, Randall LM, Anton-Culver H, Bristow RE. PMID: 25913132; PMCID: PMC5145799.
-
Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines. Obstet Gynecol. 2015 Apr; 125(4):833-842. Bristow RE, Chang J, Ziogas A, Campos B, Chavez LR, Anton-Culver H. PMID: 25751200; PMCID: PMC5167570.
-
Surgical technique of en bloc pelvic resection for advanced ovarian cancer. J Gynecol Oncol. 2015 Apr; 26(2):155. Chang SJ, Bristow RE. PMID: 25872895; PMCID: PMC4397232.
-
Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival. J Am Coll Surg. 2015 May; 220(5):940-50. Bristow RE, Chang J, Ziogas A, Campos B, Chavez LR, Anton-Culver H. PMID: 25840536; PMCID: PMC5145798.
-
Spatial analysis of advanced-stage ovarian cancer mortality in California. Am J Obstet Gynecol. 2015 Jul; 213(1):43.e1-43.e8. Bristow RE, Chang J, Ziogas A, Gillen DL, Bai L, Vieira VM. PMID: 25644440; PMCID: PMC4485540.
-
A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature. Am J Obstet Gynecol. 2015 Jun; 212(6):717-24. Liu FW, Galvan-Turner VB, Pfaendler KS, Longoria TC, Bristow RE. PMID: 25582101; PMCID: PMC4457589.
-
Evaluation of 30-day hospital readmission after surgery for advanced-stage ovarian cancer in a medicare population. J Clin Oncol. 2014 Dec 20; 32(36):4113-9. Eskander RN, Chang J, Ziogas A, Anton-Culver H, Bristow RE. PMID: 25385738; PMCID: PMC4517941.
-
Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California. Am J Obstet Gynecol. 2015 Apr; 212(4):468.e1-9. Long B, Chang J, Ziogas A, Tewari KS, Anton-Culver H, Bristow RE. PMID: 25448522.
-
Ovarian cancer in the United States: contemporary patterns of care associated with improved survival. Gynecol Oncol. 2015 Jan; 136(1):11-7. Cliby WA, Powell MA, Al-Hammadi N, Chen L, Philip Miller J, Roland PY, Mutch DG, Bristow RE. PMID: 25449311; PMCID: PMC4419829.
-
MR-guided prostate biopsy for planning of focal salvage after radiation therapy. Radiology. 2015 Jan; 274(1):181-91. Ménard C, Iupati D, Publicover J, Lee J, Abed J, O'Leary G, Simeonov A, Foltz WD, Milosevic M, Catton C, Morton G, Bristow R, Bayley A, Atenafu EG, Evans AJ, Jaffray DA, Chung P, Brock KK, Haider MA. PMID: 25203127.
-
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent ovarian carcinoma: analysis of 30-day morbidity and mortality. Ann Surg Oncol. 2015 Feb; 22(2):655-61. Cripe J, Tseng J, Eskander R, Fader AN, Tanner E, Bristow R. PMID: 25155402.
-
Clinical commentary: Medical ethics and the ramifications of equipoise in clinical research. Is a confirmatory trial using a non-bevacizumab containing arm feasible in patients with recurrent cervical cancer? Gynecol Oncol. 2014 Sep; 134(3):447-9. Krill LS, Adelson JW, Randall LM, Bristow RE. PMID: 24976631.
-
Cooperation of Blm and Mus81 in development, fertility, genomic integrity and cancer suppression. Oncogene. 2015 Apr 02; 34(14):1780-9. El Ghamrasni S, Cardoso R, Halaby MJ, Zeegers D, Harding S, Kumareswaran R, Yavorska T, Chami N, Jurisicova A, Sanchez O, Hande MP, Bristow R, Hakem R, Hakem A. PMID: 24858046.
-
Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors. Cancer Chemother Pharmacol. 2014 Jul; 74(1):195-204. Mita M, Gordon M, Rosen L, Kapoor N, Choy G, Redkar S, Taverna P, Oganesian A, Sahai A, Azab M, Bristow R, Tolcher AW. PMID: 24849582.
-
New paradigms in the surgical and adjuvant treatment of ovarian cancer. Minerva Ginecol. 2014 Apr; 66(2):179-92. Hodeib M, Eskander RN, Bristow RE. PMID: 24848076.
-
Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status. Gynecol Oncol. 2014 Jul; 134(1):60-7. Bristow RE, Chang J, Ziogas A, Anton-Culver H, Vieira VM. PMID: 24680770; PMCID: PMC4095874.
-
Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise. Curr Treat Options Oncol. 2014 Mar; 15(1):27-40. Eskander RN, Cripe J, Bristow RE. PMID: 24338278.
-
The effect of ovarian imaging on the clinical interpretation of a multivariate index assay. Am J Obstet Gynecol. 2014 Jul; 211(1):65.e1-65.e11. Goodrich ST, Bristow RE, Santoso JT, Miller RW, Smith A, Zhang Z, Ueland FR. PMID: 24530816.
-
High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease. Gynecol Oncol. 2014 Feb; 132(2):403-10. Bristow RE, Chang J, Ziogas A, Randall LM, Anton-Culver H. PMID: 24361578.
-
The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study. Gynecol Oncol. 2014 Mar; 132(3):560-5. Fader AN, Java J, Krivak TC, Bristow RE, Tergas AI, Bookman MA, Armstrong DK, Tanner EJ, Gershenson DM. PMID: 24333362; PMCID: PMC4390028.
-
Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy. Gynecol Oncol. 2014 Jan; 132(1):33-7. Gunderson CC, Dutta S, Fader AN, Maniar KP, Nasseri-Nik N, Bristow RE, Diaz-Montes TP, Palermo R, Kurman RJ. PMID: 24316307.
-
Deriving patient-specific planning target volume for partial bladder image guided radiation therapy. Pract Radiat Oncol. 2014 Sep-Oct; 4(5):323-329. Kong V, Rosewall T, Chen S, Craig T, Bristow R, Milosevic M, Kwan M, Chung P. PMID: 25194101.
-
In reply. Obstet Gynecol. 2013 Oct; 122(4):907. Bristow RE. PMID: 24084556.
-
Clinical performance of a multivariate index assay for detecting early-stage ovarian cancer. Am J Obstet Gynecol. 2014 Jan; 210(1):78.e1-9. Longoria TC, Ueland FR, Zhang Z, Chan DW, Smith A, Fung ET, Munroe DG, Bristow RE. PMID: 24055582.
-
Racial disparities and patterns of ovarian cancer surgical care in California. Gynecol Oncol. 2014 Jan; 132(1):221-6. Liu FW, Randall LM, Tewari KS, Bristow RE. PMID: 24016407; PMCID: PMC4423747.
-
Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass. Am J Obstet Gynecol. 2013 Dec; 209(6):581.e1-8. Bristow RE, Hodeib M, Smith A, Chan DW, Zhang Z, Fung ET, Tewari KS, Munroe DG, Ueland FR. PMID: 23942039.
-
Survival in women with grade 1 serous ovarian carcinoma. Obstet Gynecol. 2013 Aug; 122(2 Pt 1):225-232. Nickles Fader A, Java J, Ueda S, Bristow RE, Armstrong DK, Bookman MA, Gershenson DM, Gynecologic Oncology Group (GOG)*. PMID: 23969788; PMCID: PMC4870595.
-
Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis. Gynecol Oncol. 2013 Sep; 130(3):493-8. Chang SJ, Hodeib M, Chang J, Bristow RE. PMID: 23747291.
-
Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol. 2013 Jun; 121(6):1226-1234. Bristow RE, Chang J, Ziogas A, Anton-Culver H. PMID: 23812456.
-
Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States. Gynecol Oncol. 2013 Sep; 130(3):652-9. Long B, Liu FW, Bristow RE. PMID: 23707671; PMCID: PMC4074587.
-
The "definitive" trial of surgical cytoreduction in advanced-stage ovarian cancer. Int J Gynecol Cancer. 2013 May; 23(4):588-91. Naik R, Spirtos N, Pomel C, Bristow R, Chi D, Vergote I, Donovan J. PMID: 23611959.
-
We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies. Gynecol Oncol. 2013 Apr; 129(1):3-4. Alvarez RD, Gray HJ, Timmins PF, Gibb RK, Edelson M, Fowler JM, Havrilesky LJ, McCauley DL, Nash JD, Rahaman J, Rash JK, Rodabaugh KJ, Powell MA, Bristow RE, Brown JV, Tewari D, Cliby WA, Anastasia P, Robinson WR, Shahin MS, Cantrell LA, Cloven NG, Gold MA, Hope JM, Muntz HG, Sorosky JI, Elkas JC, Frumovitz MM, Jewell E, Spillman MA, Naumann RW. PMID: 23638463.
-
Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst. 2013 Jun 05; 105(11):823-32. Bristow RE, Powell MA, Al-Hammadi N, Chen L, Miller JP, Roland PY, Mutch DG, Cliby WA. PMID: 23539755; PMCID: PMC3691950.
-
Robotic surgery: gynecologic oncology. Cancer J. 2013 Mar-Apr; 19(2):167-76. Krill LS, Bristow RE. PMID: 23528726.
-
Surgical cytoreduction for recurrent epithelial ovarian cancer. Cochrane Database Syst Rev. 2013 Feb 28; (2):CD008765. Al Rawahi T, Lopes AD, Bristow RE, Bryant A, Elattar A, Chattopadhyay S, Galaal K. PMID: 23450588; PMCID: PMC6457850.
-
Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancer. J Gynecol Oncol. 2013 Jan; 24(1):29-36. Chang SJ, Bristow RE, Ryu HS. PMID: 23346311; PMCID: PMC3549504.
-
Impact of race and ethnicity on treatment and survival of women with vulvar cancer in the United States. Gynecol Oncol. 2013 Apr; 129(1):154-8. Tergas AI, Tseng JH, Bristow RE. PMID: 23274562.
-
Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay. Gynecol Oncol. 2013 Feb; 128(2):252-9. Bristow RE, Smith A, Zhang Z, Chan DW, Crutcher G, Fung ET, Munroe DG. PMID: 23178277.
-
Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer. J Magn Reson Imaging. 2013 Apr; 37(4):909-16. Foltz WD, Wu A, Chung P, Catton C, Bayley A, Milosevic M, Bristow R, Warde P, Simeonov A, Jaffray DA, Haider MA, Ménard C. PMID: 23097411.
-
Association between germline HOXB13 G84E mutation and risk of prostate cancer. J Natl Cancer Inst. 2012 Aug 22; 104(16):1260-2. Akbari MR, Trachtenberg J, Lee J, Tam S, Bristow R, Loblaw A, Narod SA, Nam RK. PMID: 22781434.
-
Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer. Ann Surg Oncol. 2012 Dec; 19(13):4059-67. Chang SJ, Bristow RE, Ryu HS. PMID: 22766983.
-
Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer. Gynecol Oncol. 2012 Sep; 126(3):381-6. Chang SJ, Bristow RE, Ryu HS. PMID: 22609747.
-
Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes. Gynecol Oncol. 2012 Aug; 126(2):220-3. Peiretti M, Bristow RE, Zapardiel I, Gerardi M, Zanagnolo V, Biffi R, Landoni F, Bocciolone L, Aletti GD, Maggioni A. PMID: 22555105.
-
A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer. Gynecol Oncol. 2012 Jul; 126(1):82-6. Chang SJ, Bristow RE, Ryu HS. PMID: 22516661.
-
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer. Clin Cancer Res. 2012 Apr 01; 18(7):2108-14. Milosevic M, Warde P, Ménard C, Chung P, Toi A, Ishkanian A, McLean M, Pintilie M, Sykes J, Gospodarowicz M, Catton C, Hill RP, Bristow R. PMID: 22465832.
-
Surgical management of epithelial ovarian cancer. Clin Obstet Gynecol. 2012 Mar; 55(1):75-95. Salani R, Bristow RE. PMID: 22343231.
-
Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining 'optimal' residual disease. Gynecol Oncol. 2012 May; 125(2):483-92. Chang SJ, Bristow RE. PMID: 22366151.
-
Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival. Int J Gynecol Cancer. 2012 Feb; 22(2):273-9. Giuntoli RL, Gerardi MA, Yemelyanova AV, Ueda SM, Fleury AC, Diaz-Montes TP, Bristow RE. PMID: 22146771.
-
Re: defining the limits of radical cytoreductive surgery in ovarian cancer. Gynecol Oncol. 2012 May; 125(2):509-10; author reply 508-9. Cliby W, Aletti G, Chi D, Bristow R. PMID: 22266023.
-
Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012 May; 125(2):477-82. Gunderson CC, Fader AN, Carson KA, Bristow RE. PMID: 22245711.
-
CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: a gynecologic oncology group study. Gynecol Oncol. 2012 Feb; 124(2):216-20. Gardner GJ, Baser RE, Brady MF, Bristow RE, Markman M, Spriggs D, Thaler HT. PMID: 22033034.
-
"Kegel ball" induced vaginal cuff dehiscence following radical abdominal hysterectomy: laparoscopically-assisted transvaginal retrieval. Gynecol Oncol. 2012 Jan; 124(1):170. Bristow RE. PMID: 21982045.
-
Is the easier way ever the better way? J Clin Oncol. 2011 Nov 01; 29(31):4073-5. Chi DS, Bristow RE, Armstrong DK, Karlan BY. PMID: 21931018.
-
Recurrence patterns and surveillance for patients with early stage endometrial cancer. Gynecol Oncol. 2011 Nov; 123(2):205-7. Salani R, Nagel CI, Drennen E, Bristow RE. PMID: 21820709.
-
Comparison of candidate serologic markers for type I and type II ovarian cancer. Gynecol Oncol. 2011 Sep; 122(3):560-6. Lu D, Kuhn E, Bristow RE, Giuntoli RL, Kjær SK, Shih IeM, Roden RB. PMID: 21704359; PMCID: PMC3152615.
-
Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol. 2011 Jun; 204(6):466-78. Salani R, Backes FJ, Fung MF, Holschneider CH, Parker LP, Bristow RE, Goff BA. PMID: 21752752.
-
Feasibility of intravenous gemcitabine and an intraperitoneal platinum agent in the treatment of ovarian cancer. J Chemother. 2011 Jun; 23(3):163-7. Giuntoli RL, Bristow RE, Diaz-Montes TP, Armstrong DK. PMID: 21742586; PMCID: PMC4870588.
-
Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center. Gynecol Oncol. 2011 Aug; 122(2):319-23. Bristow RE, Ueda S, Gerardi MA, Ajiboye OB, Ibeanu OA. PMID: 21632099.
-
Impact of payer status on treatment of cervical cancer at a tertiary referral center. Gynecol Oncol. 2011 Aug; 122(2):324-7. Levinson KL, Bristow RE, Donohue PK, Kanarek NF, Trimble CL. PMID: 21620446; PMCID: PMC4612589.
-
Impact of surgeon and hospital volume on short-term outcomes and cost of oropharyngeal cancer surgical care. Laryngoscope. 2011 Apr; 121(4):746-52. Gourin CG, Forastiere AA, Sanguineti G, Marur S, Koch WM, Bristow RE. PMID: 21433017; PMCID: PMC3612951.
-
Fertility preserving options in patients with gynecologic malignancies. Am J Obstet Gynecol. 2011 Aug; 205(2):103-10. Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ, Bristow RE. PMID: 21411052; PMCID: PMC5111967.
-
Volume-based trends in surgical care of patients with oropharyngeal cancer. Laryngoscope. 2011 Apr; 121(4):738-45. Gourin CG, Forastiere AA, Sanguineti G, Marur S, Koch WM, Bristow RE. PMID: 21394725.
-
Racial disparities in surgical care for uterine cancer. Gynecol Oncol. 2011 Jun 01; 121(3):571-6. Fleury AC, Ibeanu OA, Bristow RE. PMID: 21354600.
-
Racial disparities in ovarian cancer surgical care: a population-based analysis. Gynecol Oncol. 2011 May 01; 121(2):364-8. Bristow RE, Zahurak ML, Ibeanu OA. PMID: 21288564.
-
Volume-based trends in laryngeal cancer surgery. Laryngoscope. 2011 Jan; 121(1):77-84. Gourin CG, Forastiere AA, Sanguineti G, Marur S, Koch WM, Bristow RE. PMID: 21125633.
-
Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care. Laryngoscope. 2011 Jan; 121(1):85-90. Gourin CG, Forastiere AA, Sanguineti G, Koch WM, Marur S, Bristow RE. PMID: 21181983.
-
Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers. Gynecol Oncol. 2011 Feb; 120(2):220-3. Krill LS, Ueda SM, Gerardi M, Bristow RE. PMID: 21145096.
-
Volume-based trends in thyroid surgery. Arch Otolaryngol Head Neck Surg. 2010 Dec; 136(12):1191-8. Gourin CG, Tufano RP, Forastiere AA, Koch WM, Pawlik TM, Bristow RE. PMID: 21173367.
-
Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial. J Clin Oncol. 2011 Jan 01; 29(1):69-75. Matei D, Sill MW, Lankes HA, DeGeest K, Bristow RE, Mutch D, Yamada SD, Cohn D, Calvert V, Farley J, Petricoin EF, Birrer MJ. PMID: 21098323; PMCID: PMC3055861.
-
The Roles of Fluorodeoxyglucose-PET/Computed Tomography in Ovarian Cancer: Diagnosis, Assessing Response, and Detecting Recurrence. PET Clin. 2010 Oct; 5(4):447-61. Wahl RL, Javadi MS, Eslamy H, Shruti A, Bristow R. PMID: 27157972.
-
Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment. Gynecol Oncol. 2011 Jan; 120(1):23-8. Aletti GD, Eisenhauer EL, Santillan A, Axtell A, Aletti G, Holschneider C, Chi DS, Bristow RE, Cliby WA. PMID: 20933255.
-
Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer. Gynecol Oncol. 2010 Nov; 119(2):255-8. Bashir S, Gerardi MA, Giuntoli RL, Montes TP, Bristow RE. PMID: 20739051.
-
Correlation of extreme drug resistant assay results and progression-free survival following intraperitoneal chemotherapy for advanced ovarian cancer. J Chemother. 2010 Aug; 22(4):270-4. Pant AC, Diaz-Montes T, Tanner E, Ahmad S, Giuntoli RL, Holloway RW, Bristow RE. PMID: 20685633.
-
Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis. Gynecol Oncol. 2010 Jul; 118(1):14-8. Barlin JN, Puri I, Bristow RE. PMID: 20434198.
-
The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol. 2010 Sep; 118(3):262-7. Bristow RE, Palis BE, Chi DS, Cliby WA. PMID: 20573392.
-
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer. Cochrane Database Syst Rev. 2010 Jun 16; (6):CD007822. Galaal K, Naik R, Bristow RE, Patel A, Bryant A, Dickinson HO. PMID: 20556785; PMCID: PMC4170993.
-
Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas. J Oncol. 2010; 2010:285191. Ueda SM, Yap KL, Davidson B, Tian Y, Murthy V, Wang TL, Visvanathan K, Kuhajda FP, Bristow RE, Zhang H, Shih IeM. PMID: 20508725; PMCID: PMC2873657.
-
Computed tomographic peritoneography prior to intraperitoneal chemotherapy in advanced Müllerian cancer: a pilot study. Clin Imaging. 2010 May-Jun; 34(3):191-5. Barlin JN, Bristow RE, Bleich K, Giuntoli RL, Thompson S, Diaz-Montes TP. PMID: 20416483.
-
Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia. J Reprod Med. 2010 Mar-Apr; 55(3-4):129-33. Barlin JN, Bristow RE, Murillo AM, Zahurak M, Veras E, Salani R. PMID: 20506673.
-
Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias? Gynecol Oncol. 2010 May; 117(2):336-40. Tanner EJ, Chi DS, Eisenhauer EL, Diaz-Montes TP, Santillan A, Bristow RE. PMID: 20153027.
-
Predicting the outcome of cytoreductive surgery for advanced ovarian cancer: a review. Int J Gynecol Cancer. 2010 Jan; 20 Suppl 1:S1-11. Ibeanu OA, Bristow RE. PMID: 20065732.
-
Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93. Am J Pathol. 2009 Dec; 175(6):2618-24. Ueda SM, Mao TL, Kuhajda FP, Vasoontara C, Giuntoli RL, Bristow RE, Kurman RJ, Shih IeM. PMID: 19893031; PMCID: PMC2789637.
-
Image guided dose escalated prostate radiotherapy: still room to improve. Radiat Oncol. 2009 Nov 03; 4:50. Martin JM, Bayley A, Bristow R, Chung P, Gospodarowicz M, Menard C, Milosevic M, Rosewall T, Warde PR, Catton CN. PMID: 19887007; PMCID: PMC2777178.
-
Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes. Gynecol Oncol. 2009 Dec; 115(3):334-8. Bristow RE, Zahurak ML, Diaz-Montes TP, Giuntoli RL, Armstrong DK. PMID: 19766295.
-
Analysis of contemporary trends in access to high-volume ovarian cancer surgical care. Ann Surg Oncol. 2009 Dec; 16(12):3422-30. Bristow RE, Puri I, Diaz-Montes TP, Giuntoli RL, Armstrong DK. PMID: 19711131.
-
Advanced cytoreductive surgery in gynecologic oncology. Gynecol Oncol. 2009 Aug; 114(2 Suppl):S1-2. Bristow RE. PMID: 19573698.
-
Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity. Anticancer Res. 2009 Aug; 29(8):2875-84. Giuntoli RL, Webb TJ, Zoso A, Rogers O, Diaz-Montes TP, Bristow RE, Oelke M. PMID: 19661290.
-
Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer. 2009 Jul 20; 9:244. Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ. PMID: 19619303; PMCID: PMC2719664.
-
In response to: Establishing evidence for change in ovarian cancer surgery - Proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis. Gynecol Oncol. 2009 Oct; 115(1):168-169. Chi DS, Bristow RE. PMID: 30036930.
-
Cytoreductive surgery for advanced and recurrent endometrial cancer: a review of the literature. Womens Health (Lond). 2009 Jul; 5(4):403-11. Barlin JN, Ueda SM, Bristow RE. PMID: 19586432.
-
Radical surgical cytoreduction of progressive leiomyomatosis peritonealis disseminata: a case report. J Reprod Med. 2009 Jul; 54(7):447-50. Kratz KG, Santillan A, Gu M, Bristow RE. PMID: 19691262.
-
Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome. Gynecol Oncol. 2009 Aug; 114(2):173-7. Bristow RE, Peiretti M, Gerardi M, Zanagnolo V, Ueda S, Diaz-Montes T, Giuntoli RL, Maggioni A. PMID: 19482344.
-
Imaging uterine cervical cancer with FDG-PET/CT: direct comparison with PET. Mol Imaging Biol. 2009 Jul-Aug; 11(4):229-35. Tatsumi M, Cohade C, Bristow RE, Wahl RL. PMID: 19434463.
-
Uterine Neoplasms. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2009 May; 7(5):498-531. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos SM, Cho KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jaggernauth W, Kapp DS, Kavanagh JJ, Lurain JR, Morgan M, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W, Teng N. PMID: 19460278.
-
p53 autoantibodies, cytokine levels and ovarian carcinogenesis. Gynecol Oncol. 2009 Jul; 114(1):12-7. Tsai-Turton M, Santillan A, Lu D, Bristow RE, Chan KC, Shih IeM, Roden RB. PMID: 19398128; PMCID: PMC2694938.
-
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol. 2009 Jul; 114(1):26-31. Chi DS, Eisenhauer EL, Zivanovic O, Sonoda Y, Abu-Rustum NR, Levine DA, Guile MW, Bristow RE, Aghajanian C, Barakat RR. PMID: 19395008.
-
Human chorionic gonadotropin production by a benign lung nodule. Int J Gynaecol Obstet. 2009 Jun; 105(3):263. Levinson K, Nasaar H, Bristow R. PMID: 19249050.
-
A practical framework for patient care teams to prospectively identify and mitigate clinical hazards. Jt Comm J Qual Patient Saf. 2009 Feb; 35(2):72-81. Herzer KR, Rodriguez-Paz JM, Doyle PA, Flint PW, Feller-Kopman DJ, Herman J, Bristow RE, Cover R, Pronovost PJ, Mark LJ. PMID: 19241727.
-
Predicting surgical outcome for advanced ovarian cancer, surgical standards of care, and the concept of kaizen. Gynecol Oncol. 2009 Jan; 112(1):1-3. Bristow RE. PMID: 19100914.
-
Metastatic leiomyosarcoma diagnosed after uterine artery embolization. Eur J Gynaecol Oncol. 2009; 30(2):199-202. Posy HE, Elkas JC, Yemelyanova AV, Diaz-Montes TP, Bristow RE, Giuntoli RL. PMID: 19480255.
-
Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 2009 Apr; 136(4):1251-60. Cleary SP, Cotterchio M, Jenkins MA, Kim H, Bristow R, Green R, Haile R, Hopper JL, LeMarchand L, Lindor N, Parfrey P, Potter J, Younghusband B, Gallinger S. PMID: 19245865; PMCID: PMC2739726.
-
Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status. Am J Obstet Gynecol. 2009 Feb; 200(2):182.e1-5. Salani R, Puri I, Bristow RE. PMID: 19019325.
-
Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor. Clin Cancer Res. 2008 Nov 15; 14(22):7340-7. Bazzaro M, Lin Z, Santillan A, Lee MK, Wang MC, Chan KC, Bristow RE, Mazitschek R, Bradner J, Roden RB. PMID: 19010849; PMCID: PMC2744414.
-
Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol Oncol. 2009 Jan; 112(1):265-74. Bristow RE, Puri I, Chi DS. PMID: 18937969.
-
Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer. J Surg Oncol. 2008 Sep 15; 98(4):283-90. Helm CW, Bristow RE, Kusamura S, Baratti D, Deraco M. PMID: 18726895.
-
Surgical care of young women diagnosed with ovarian cancer: a population-based perspective. Gynecol Oncol. 2008 Nov; 111(2):221-5. Tanner EJ, Zahurak ML, Bristow RE, Díaz-Montes TP. PMID: 18786718.
-
Explained compared with unexplained fever in postoperative myomectomy and hysterectomy patients. Obstet Gynecol. 2008 May; 111(5):1137-42. Rybak EA, Polotsky AJ, Woreta T, Hailpern SM, Bristow RE. PMID: 18448746.
-
Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice. Gynecol Oncol. 2008 Jun; 109(3):388-93. Santillan A, Govan L, Zahurak ML, Diaz-Montes TP, Giuntoli RL, Bristow RE. PMID: 18405946.
-
Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome. Gynecol Oncol. 2008 Jun; 109(3):364-9. Bristow RE, Peiretti M, Zanagnolo V, Salani R, Giuntoli RL, Maggioni A. PMID: 18396322.
-
Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement. Int J Gynecol Pathol. 2008 Apr; 27(2):182-90. Judson K, McCormick C, Vang R, Yemelyanova AV, Wu LS, Bristow RE, Ronnett BM. PMID: 18317225.
-
Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer. Gynecol Oncol. 2008 Feb; 108(2):271-5. Salani R, Axtell A, Gerardi M, Holschneider C, Bristow RE. PMID: 18164380.
-
Cervical cancer. J Natl Compr Canc Netw. 2008 Jan; 6(1):14-36. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Huh WK, Jaggernauth W, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR, Morgan M, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Secord AA, Small W, Teng N, National Comprehensive Cancer Network. PMID: 18267056.
-
A clinical pathway for patients undergoing primary cytoreductive surgery with rectosigmoid colectomy for advanced ovarian and primary peritoneal cancers. Gynecol Oncol. 2008 Feb; 108(2):282-6. Gerardi MA, Santillan A, Meisner B, Zahurak ML, Diaz Montes TP, Giuntoli RL, Bristow RE. PMID: 18023851.
-
Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma. Ann Surg Oncol. 2007 Dec; 14(12):3552-7. Salani R, Diaz-Montes T, Giuntoli RL, Bristow RE. PMID: 17896149.
-
Myosin II co-chaperone general cell UNC-45 overexpression is associated with ovarian cancer, rapid proliferation, and motility. Am J Pathol. 2007 Nov; 171(5):1640-9. Bazzaro M, Santillan A, Lin Z, Tang T, Lee MK, Bristow RE, Shih IeM, Roden RB. PMID: 17872978; PMCID: PMC2043524.
-
Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study. Gynecol Oncol. 2007 Dec; 107(3):495-9. Salani R, Zahurak ML, Santillan A, Giuntoli RL, Bristow RE. PMID: 17854870.
-
Predictors of extended intensive care unit resource utilization following surgery for ovarian cancer. Gynecol Oncol. 2007 Dec; 107(3):464-8. Díaz-Montes TP, Zahurak ML, Bristow RE. PMID: 17765297.
-
Concentration of uterine cancer surgical care among the elderly: a population-based perspective. Gynecol Oncol. 2007 Dec; 107(3):436-40. Díaz-Montes TP, Zahurak ML, Giuntoli RL, Bristow RE. PMID: 17764726.
-
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance. Int J Gynecol Cancer. 2008 May-Jun; 18(3):487-91. Salani R, Kurman RJ, Giuntoli R, Gardner G, Bristow R, Wang TL, Shih IM. PMID: 17692090.
-
Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis. Gynecol Oncol. 2007 Sep; 106(3):476-81. Bristow RE, Santillan A, Salani R, Diaz-Montes TP, Giuntoli RL, Meisner BC, Armstrong DK, Frick KD. PMID: 17688927.
-
Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol. 2007 Jul; 31(7):988-98. Wheeler DT, Bristow RE, Kurman RJ. PMID: 17592264.
-
A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model. Gynecol Oncol. 2007 Oct; 107(1):99-106. Aletti GD, Santillan A, Eisenhauer EL, Hu J, Aletti G, Podratz KC, Bristow RE, Chi DS, Cliby WA. PMID: 17602726.
-
Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma. Int J Gynecol Cancer. 2007 May-Jun; 17(3):601-6. Santillan A, Kim YW, Zahurak ML, Gardner GJ, Giuntoli RL, Shih IM, Bristow RE. PMID: 17504374.
-
Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma. Gynecol Oncol. 2007 Jul; 106(1):82-8. Giuntoli RL, Garrett-Mayer E, Bristow RE, Gostout BS. PMID: 17434579.
-
Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis. Cancer. 2007 Apr 15; 109(8):1513-22. Bristow RE, Santillan A, Diaz-Montes TP, Gardner GJ, Giuntoli RL, Meisner BC, Frick KD, Armstrong DK. PMID: 17354232.
-
The role of cytoreductive surgery for colon cancer metastatic to the ovary. Gynecol Oncol. 2007 Jun; 105(3):791-5. McCormick CC, Giuntoli RL, Gardner GJ, Schulick RD, Judson K, Ronnett BM, Vang R, Bristow RE. PMID: 17408727.
-
Expression of extracellular matrix proteins in ovarian serous tumors. Int J Gynecol Pathol. 2007 Apr; 26(2):141-6. Salani R, Neuberger I, Kurman RJ, Bristow RE, Chang HW, Wang TL, Shih IeM. PMID: 17413980.
-
A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: a Gynecologic Oncology Group study. Gynecol Oncol. 2007 Jun; 105(3):667-71. Armstrong DK, Bookman MA, McGuire W, Bristow RE, Schilder JM, Gynecologic Oncology Group. PMID: 17368526; PMCID: PMC1987371.
-
Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome. Cancer. 2007 Feb 15; 109(4):685-91. Salani R, Santillan A, Zahurak ML, Giuntoli RL, Gardner GJ, Armstrong DK, Bristow RE. PMID: 17219441.
-
Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol. 2007 Feb 01; 25(4):384-9. Axtell AE, Lee MH, Bristow RE, Dowdy SC, Cliby WA, Raman S, Weaver JP, Gabbay M, Ngo M, Lentz S, Cass I, Li AJ, Karlan BY, Holschneider CH. PMID: 17264334.
-
Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction. Gynecol Oncol. 2007 Feb; 104(2):480-90. Bristow RE, Eisenhauer EL, Santillan A, Chi DS. PMID: 17166564.
-
Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer. Gynecol Oncol. 2007 Mar; 104(3):686-90. Santillan A, Karam AK, Li AJ, Giuntoli R, Gardner GJ, Cass I, Karlan BY, Bristow RE. PMID: 17141302.
-
A randomized phase III study of neoadjuvant hormonal therapy in patients with localized prostate cancer. Clin Genitourin Cancer. 2006 Dec; 5(3):235-7. Warde P, Tsuji D, Bristow R. PMID: 17239279.
-
A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival. Proc Natl Acad Sci U S A. 2006 Dec 05; 103(49):18739-44. Nakayama K, Nakayama N, Davidson B, Sheu JJ, Jinawath N, Santillan A, Salani R, Bristow RE, Morin PJ, Kurman RJ, Wang TL, Shih IeM. PMID: 17130457; PMCID: PMC1693732.
-
Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis. Gynecol Oncol. 2007 Mar; 104(3):739-46. Bristow RE, Santillan A, Diaz-Montes TP, Gardner GJ, Giuntoli RL, Peeler ST. PMID: 17097723.
-
Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results. Gynecol Oncol. 2007 Feb; 104(2):366-71. Diaz-Montes TP, Farinola MA, Zahurak ML, Bristow RE, Rosenthal DL. PMID: 17049972.
-
Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome. Gynecol Oncol. 2007 Feb; 104(2):377-80. Karam AK, Santillan A, Bristow RE, Giuntoli R, Gardner GJ, Cass I, Karlan BY, Li AJ. PMID: 17014899.
-
Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol. 2006 Sep; 49(3):492-505. Giuntoli RL, Vang RS, Bristow RE. PMID: 16885656.
-
Uterine cancer in Maryland: impact of surgeon case volume and other prognostic factors on short-term mortality. Gynecol Oncol. 2006 Dec; 103(3):1043-7. Díaz-Montes TP, Zahurak ML, Giuntoli RL, Gardner GJ, Bristow RE. PMID: 16876234.
-
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Gynecol Oncol. 2006 Dec; 103(3):1070-6. Bristow RE, Chi DS. PMID: 16875720.
-
Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer. Gynecol Oncol. 2006 Dec; 103(3):1048-53. Alphs HH, Zahurak ML, Bristow RE, Díaz-Montes TP. PMID: 16876237.
-
Impact of surgeon specialty on ovarian-conserving surgery in young females with an adnexal mass. J Adolesc Health. 2006 Sep; 39(3):411-6. Bristow RE, Nugent AC, Zahurak ML, Khouzhami V, Fox HE. PMID: 16919804.
-
Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance. Gynecol Oncol. 2006 Nov; 103(2):709-13. Bristow RE, Purinton SC, Santillan A, Diaz-Montes TP, Gardner GJ, Giuntoli RL. PMID: 16797686.
-
Surgery for ovarian cancer: how to improve survival. Lancet. 2006 May 13; 367(9522):1558-60. Bristow RE, Berek JS. PMID: 16698396.
-
Salvage cytoreductive surgery for recurrent endometrial cancer. Gynecol Oncol. 2006 Oct; 103(1):281-7. Bristow RE, Santillan A, Zahurak ML, Gardner GJ, Giuntoli RL, Armstrong DK. PMID: 16631236.
-
Uterine cancers. J Natl Compr Canc Netw. 2006 May; 4(5):438-62. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Jaggernauth W, Jhingran A, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR, Morgan RJ, Nag S, Partridge EE, Powell CB, Remmenga SW, Reynolds RK, Small W, Soper J, Teng N, National Comprehensive Cancer Network. PMID: 16687093.
-
Predicting "unresectable" ovarian cancer: Taking aim at a moving target. Gynecol Oncol. 2006 Mar; 100(3):449-50. Bristow RE. PMID: 16488272.
-
Paraneoplastic cerebellar degeneration in a woman with ovarian cancer. Nat Clin Pract Oncol. 2006 Feb; 3(2):108-12; quiz 1 p following 112. Santillan A, Bristow RE. PMID: 16462852.
-
Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst. 2006 Feb 01; 98(3):163-71. Schrag D, Earle C, Xu F, Panageas KS, Yabroff KR, Bristow RE, Trimble EL, Warren JL. PMID: 16449676.
-
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006 Feb 01; 98(3):172-80. Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, Trimble EL, Bodurka DC, Bristow RE, Carney M, Warren JL. PMID: 16449677.
-
Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range. J Clin Oncol. 2005 Dec 20; 23(36):9338-43. Santillan A, Garg R, Zahurak ML, Gardner GJ, Giuntoli RL, Armstrong DK, Bristow RE. PMID: 16361633.
-
Primary insular carcinoid of the ovary. Gynecol Oncol. 2006 Apr; 101(1):175-8. Díaz-Montes TP, Rosenthal LE, Bristow RE, Grumbine FC. PMID: 16298421.
-
Secondary cytoreduction for patients with recurrent ovarian cancer. Curr Oncol Rep. 2005 Nov; 7(6):451-8. Díaz-Montes TP, Bristow RE. PMID: 16221382.
-
Abdominal carcinomatosis in women with a history of breast cancer. Gynecol Oncol. 2005 Oct; 99(1):65-70. Garg R, Zahurak ML, Trimble EL, Armstrong DK, Bristow RE. PMID: 15979132.
-
Clinical significance of Her-2/neu overexpression in uterine serous carcinoma. Gynecol Oncol. 2006 Jan; 100(1):139-44. Díaz-Montes TP, Ji H, Smith Sehdev AE, Zahurak ML, Kurman RJ, Armstrong DK, Bristow RE. PMID: 16182348.
-
Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. Proc Natl Acad Sci U S A. 2005 Sep 27; 102(39):14004-9. Shih IeM, Sheu JJ, Santillan A, Nakayama K, Yen MJ, Bristow RE, Vang R, Parmigiani G, Kurman RJ, Trope CG, Davidson B, Wang TL. PMID: 16172393; PMCID: PMC1236547.
-
Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac. Gynecol Oncol. 2005 Sep; 98(3):510-2. Díaz-Montes TP, Jacene HA, Wahl RL, Bristow RE. PMID: 15992914.
-
Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier. Gynecol Oncol. 2005 Nov; 99(2):301-8. Bristow RE, Montz FJ. PMID: 16085295.
-
Surgical care of elderly women with ovarian cancer: a population-based perspective. Gynecol Oncol. 2005 Nov; 99(2):352-7. Díaz-Montes TP, Zahurak ML, Giuntoli RL, Gardner GJ, Gordon TA, Armstrong DK, Bristow RE. PMID: 16055176.
-
Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol Oncol. 2005 Nov; 99(2):294-300. Bristow RE, Giuntoli RL, Pannu HK, Schulick RD, Fishman EK, Wahl RL. PMID: 16051330.
-
Stage IV micropapillary serous ovarian carcinoma: a report of three cases. Int J Gynecol Pathol. 2005 Jul; 24(3):235-8. Kim YW, Srodon M, Bristow RE. PMID: 15968198.
-
Cancer of the uterine corpus among Hispanic women living in the United States: patterns of staging, diagnosis, and primary treatment. Gynecol Oncol. 2005 Mar; 96(3):753-9. Díaz-Montes TP, Alberg A, Zahurak ML, Trimble EL, Bristow RE. PMID: 15721422.
-
Ovarian malignancy in breast cancer patients with an adnexal mass. Obstet Gynecol. 2005 Mar; 105(3):507-13. Simpkins F, Zahurak M, Armstrong D, Grumbine F, Bristow R. PMID: 15738016.
-
Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations. Cancer Res. 2005 Mar 01; 65(5):1994-2000. Pohl G, Ho CL, Kurman RJ, Bristow R, Wang TL, Shih IeM. PMID: 15753399.
-
Cervical cancer guidelines. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2004 Nov; 2(6):612-30. Teng N, Abu-Rustum NR, Bahador A, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Fiorica J, Greer BE, Kapp DS, Kavanagh J, Koh WJ, Kuettel M, Lurain JR, Molpus KL, Nag S, Partridge EE, Powell CB, Reynolds RK, Small W, Soper J, Tillmanns TD, National Comprehensive Cancer Network. PMID: 19780304.
-
Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas. Clin Cancer Res. 2004 Oct 01; 10(19):6432-6. Hsu CY, Bristow R, Cha MS, Wang BG, Ho CL, Kurman RJ, Wang TL, Shih IeM. PMID: 15475429.
-
Uterine leiomyosarcoma: present management. Curr Opin Oncol. 2004 Jul; 16(4):324-7. Giuntoli RL, Bristow RE. PMID: 15187886.
-
Secondary cytoreductive surgery for isolated nodal recurrence of ovarian cancer. Ann Surg Oncol. 2004 Jul; 11(7):639-40. Bristow RE. PMID: 15197010.
-
Role of obesity in the surgical management of advanced-stage ovarian cancer. J Reprod Med. 2004 Jun; 49(6):473-6. Wolfberg AJ, Montz FJ, Bristow RE. PMID: 15283057.
-
Ovarian cancer surgery in Maryland: volume-based access to care. Gynecol Oncol. 2004 May; 93(2):353-60. Bristow RE, Zahurak ML, del Carmen MG, Gordon TA, Fox HE, Trimble EL, Montz FJ. PMID: 15099945.
-
PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation. Abdom Imaging. 2004 May-Jun; 29(3):398-403. Pannu HK, Cohade C, Bristow RE, Fishman EK, Wahl RL. PMID: 15354347.
-
A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother Oncol. 2004 Jan; 70(1):37-44. Bayley AJ, Catton CN, Haycocks T, Kelly V, Alasti H, Bristow R, Catton P, Crook J, Gospodarowicz MK, McLean M, Milosevic M, Warde P. PMID: 15036850.
-
Inability of immunohistochemistry to predict clinical outcomes of endometrial cancer patients. Int J Gynecol Cancer. 2004 Jan-Feb; 14(1):145-51. Gossett DR, Alo P, Bristow RE, Galati M, Kyshtoobayeva A, Fruehauf J, Montz FJ. PMID: 14764043.
-
PET-CT in recurrent ovarian cancer: initial observations. Radiographics. 2004 Jan-Feb; 24(1):209-23. Pannu HK, Bristow RE, Cohade C, Fishman EK, Wahl RL. PMID: 14730047.
-
Comment on "Tumor response to radiotherapy regulated by endothelial cell apoptosis" (II). Science. 2003 Dec 12; 302(5652):1894; author reply 1894. Brown M, Bristow R, Glazer P, Hill R, McBride W, McKenna G, Muschel R. PMID: 14671275.
-
Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors. Cancer. 2003 Oct 15; 98(8):1658-63. Del Carmen MG, Smith Sehdev AE, Fader AN, Zahurak ML, Richardson M, Fruehauf JP, Montz FJ, Bristow RE. PMID: 14534882.
-
Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer. J Am Coll Surg. 2003 Oct; 197(4):565-74. Bristow RE, del Carmen MG, Kaufman HS, Montz FJ. PMID: 14522325.
-
Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol. 2003 Sep; 90(3):519-28. Bristow RE, del Carmen MG, Pannu HK, Cohade C, Zahurak ML, Fishman EK, Wahl RL, Montz FJ. PMID: 13678719.
-
Argon beam coagulation facilitates management of placenta percreta with bladder invasion. Obstet Gynecol. 2003 Sep; 102(3):555-6. Karam AK, Bristow RE, Bienstock J, Montz FJ. PMID: 12962942.
-
FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer. 2003 Sep-Oct; 13(5):664-72. Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Montz FJ. PMID: 14675352.
-
Ovarian cancer in elderly women. Oncology (Williston Park). 2003 Aug; 17(8):1075-81; discussion 1081, 1085-6, 1091. Lambrou NC, Bristow RE. PMID: 12966676.
-
Increased plasma DNA integrity in cancer patients. Cancer Res. 2003 Jul 15; 63(14):3966-8. Wang BG, Huang HY, Chen YC, Bristow RE, Kassauei K, Cheng CC, Roden R, Sokoll LJ, Chan DW, Shih IeM. PMID: 12873992.
-
Multidetector CT of peritoneal carcinomatosis from ovarian cancer. Radiographics. 2003 May-Jun; 23(3):687-701. Pannu HK, Bristow RE, Montz FJ, Fishman EK. PMID: 12740470.
-
Cancer and pregnancy: recent developments. Curr Opin Obstet Gynecol. 2002 Dec; 14(6):613-7. Ward RM, Bristow RE. PMID: 12441701.
-
FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival. Int J Gynecol Cancer. 2002 Sep-Oct; 12(5):454-8. Memarzadeh S, Holschneider CH, Bristow RE, Jones NL, Fu YS, Karlan BY, Berek JS, Farias-Eisner R. PMID: 12366662.
-
Recurrent micropapillary serous ovarian carcinoma. Cancer. 2002 Aug 15; 95(4):791-800. Bristow RE, Gossett DR, Shook DR, Zahurak ML, Tomacruz RS, Armstrong DK, Montz FJ. PMID: 12209723.
-
Struma ovarii associated with pseudo-Meigs' syndrome and elevated serum CA 125. Gynecol Oncol. 2002 Aug; 86(2):231-4. Huh JJ, Montz FJ, Bristow RE. PMID: 12144834.
-
Micropapillary serous ovarian carcinoma: surgical management and clinical outcome. Gynecol Oncol. 2002 Aug; 86(2):163-70. Bristow RE, Gossett DR, Shook DR, Zahurak ML, Tomacruz RS, Armstrong DK, Montz FJ. PMID: 12144823.
-
Cystic paracervical mass as an unusual sequela of graft-versus-host disease. A case report. J Reprod Med. 2002 Jul; 47(7):600-2. Gossett DR, Montz FJ, Bristow RE. PMID: 12170542.
-
Decreased incidence of cervical cancer in medicare-eligible California women. Obstet Gynecol. 2002 Jul; 100(1):79-86. Cornelison TL, Montz FJ, Bristow RE, Chou B, Bovicelli A, Zeger SL. PMID: 12100807.
-
Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancer. Gynecol Oncol. 2002 Apr; 85(1):196-200. Bristow RE, Simpkins F, Pannu HK, Fishman EK, Montz FJ. PMID: 11925145.
-
Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol. 2002 Apr; 186(4):651-7. Montz FJ, Bristow RE, Bovicelli A, Tomacruz R, Kurman RJ. PMID: 11967486.
-
Gynecologic abnormalities in surgically treated women with stage II or III rectal cancer. J Am Coll Surg. 2002 Mar; 194(3):315-23. Becker SO, Tomacruz R, Kaufman HS, Bristow RE, Montz FJ. PMID: 11893135.
-
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002 Mar 01; 20(5):1248-59. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. PMID: 11870167.
-
Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator. Gynecol Oncol. 2001 Oct; 83(1):39-48. Bristow RE, Montz FJ. PMID: 11585412.
-
Ablation of metastatic ovarian carcinoma with the argon beam coagulator: pathologic analysis of tumor destruction. Gynecol Oncol. 2001 Oct; 83(1):49-55. Bristow RE, Smith Sehdev AE, Kaufman HS, Montz FJ. PMID: 11585413.
-
Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix. Curr Opin Oncol. 2001 Sep; 13(5):394-8. Shipman SD, Bristow RE. PMID: 11555719.
-
Management of pelvic hemorrhage. Surg Clin North Am. 2001 Aug; 81(4):925-48. Tomacruz RS, Bristow RE, Montz FJ. PMID: 11551134.
-
Leiomyomatosis peritonealis disseminata and ovarian Brenner tumor associated with tamoxifen use. Int J Gynecol Cancer. 2001 Jul-Aug; 11(4):312-5. Bristow RE, Montz FJ. PMID: 11520371.
-
Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease. Gynecol Oncol. 2001 May; 81(2):279-86. Bristow RE, Asrari F, Trimble EL, Montz FJ. PMID: 11330963.
-
Impact of increasing Papanicolaou test sensitivity and compliance: a modeled cost and outcomes analysis. Obstet Gynecol. 2001 May; 97(5 Pt 1):781-8. Montz FJ, Farber FL, Bristow RE, Cornelison T. PMID: 11339934.
-
The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma. Gynecol Oncol. 2001 Apr; 81(1):92-9. Bristow RE, Duska LR, Montz FJ. PMID: 11277657.
-
Coexistent choriocarcinoma and malignant mixed mesodermal tumor of the uterus. Gynecol Oncol. 2000 Dec; 79(3):499-503. Nguyen CP, Levi AW, Montz FJ, Bristow RE. PMID: 11104628.
-
Retrograde seeding of malignant cells during hysteroscopy in presumed early endometrial cancer. Gynecol Oncol. 2000 Oct; 79(1):55-8. Zerbe MJ, Zhang J, Bristow RE, Grumbine FC, Abularach S, Montz FJ. PMID: 11006031.
-
A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer. 2000 Oct 01; 89(7):1532-40. Bristow RE, Duska LR, Lambrou NC, Fishman EK, O'Neill MJ, Trimble EL, Montz FJ. PMID: 11013368.
-
Management of stage I cervical cancer in pregnancy. Obstet Gynecol Surv. 2000 Oct; 55(10):633-43. Nguyen C, Montz FJ, Bristow RE. PMID: 11023204.
-
Surgical standards in the management of ovarian cancer. Curr Opin Oncol. 2000 Sep; 12(5):474-80. Bristow RE. PMID: 10975556.
-
A radical debulking of leiomyomatosis peritonealis disseminata from a colonic obstruction: a case report and review of the literature. J Am Coll Surg. 2000 Aug; 191(2):212-5. Ghosh K, Dorigo O, Bristow R, Berek J. PMID: 10945368.
-
Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol. 2000 Aug; 78(2):85-91. Bristow RE, Zerbe MJ, Rosenshein NB, Grumbine FC, Montz FJ. PMID: 10926785.
-
Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporal spread in endometrial cancer. Gynecol Oncol. 2000 Jul; 78(1):67-70. Zerbe MJ, Bristow R, Grumbine FC, Montz FJ. PMID: 10873413.
-
The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population. Am J Obstet Gynecol. 2000 Jun; 182(6):1278-82. Chin AB, Bristow RE, Korst LM, Walts A, Lagasse LD. PMID: 10871439.
-
Workup of the abnormal Pap test. Clin Cornerstone. 2000; 3(1):12-24. Bristow RE, Montz FJ. PMID: 11061064.
-
Ethnic differences in patterns of care of stage 1A(1) and stage 1A(2) cervical cancer: a SEER database study. Gynecol Oncol. 1999 Oct; 75(1):113-7. del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E. PMID: 10502436.
-
Endometrial cancer. Curr Opin Oncol. 1999 Sep; 11(5):388-93. Bristow RE. PMID: 10505777.
-
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol. 1999 Mar; 72(3):278-87. Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY. PMID: 10053096.
-
Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma. Cancer. 1999 Feb 01; 85(3):658-68. Bristow RE, Baldwin RL, Yamada SD, Korc M, Karlan BY. PMID: 10091739.
-
Psammocarcinoma with an aggressive course. Obstet Gynecol. 1998 Oct; 92(4 Pt 2):659-61. Poggi SH, Bristow RE, Nieberg RK, Berek JS. PMID: 9764653.
-
Complete hydatidiform mole and surviving coexistent twin. Obstet Gynecol Surv. 1996 Dec; 51(12):705-9. Bristow RE, Shumway JB, Khouzami AN, Witter FR. PMID: 8972493.
-
Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature. Cancer. 1996 Nov 15; 78(10):2049-62. Bristow RE, Lagasse LD, Karlan BY. PMID: 8918397.
-
Ovulation induction, infertility, and ovarian cancer risk. Fertil Steril. 1996 Oct; 66(4):499-507. Bristow RE, Karlan BY. PMID: 8816606.
-
The risk of ovarian cancer after treatment for infertility. Curr Opin Obstet Gynecol. 1996 Feb; 8(1):32-7. Bristow RE, Karlan BY. PMID: 8777256.
-
Uterine rupture associated with recent antepartum cocaine abuse. Obstet Gynecol. 1994 May; 83(5 Pt 2):840-1. Iriye BK, Bristow RE, Hsu CD, Bruni R, Johnson TR. PMID: 8159370.
US